A tablet tool may empower women to prevent HIV — trial puts it to the test

NCT ID NCT04621760

First seen Jul 31, 2026 · Last updated Jul 31, 2026

Summary

This trial tests a tablet-based decision support tool designed to help women learn about their HIV risk and prevention options, including PrEP. Women aged 18-45 who are not living with HIV will be randomly assigned to use the tool before a clinic visit or to receive standard counseling. Researchers will survey participants about their knowledge, confidence, and satisfaction, and follow up after three months to see if they started an HIV prevention method. The goal is to see if the tool increases PrEP use and improves decision-making.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
A tablet-based decision support tool that educates women about HIV prevention options, including PrEP.
What this could lead to
If effective, this tool could help more women at risk of HIV start using PrEP or other prevention methods, potentially reducing HIV rates among women of color.
What could go wrong
The trial is small and tests a behavioral tool, not a drug. Results may not apply broadly, and the tool's impact on actual HIV prevention is uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Florida Department of Health in Duval County

    Jacksonville, Florida, 32211, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.